Page 15 - AN-1-1
P. 15

Advanced Neurology                                                          AIS in patients with COVID-19




            Table 2. Characteristics and outcomes of acute ischemic stroke patients with COVID-19 versus those without COVID-19.
             Variables   No. of   AIS patients  AIS patients   OR (95% CI)   OR (95% CI)   P  I 2 heterogeeneity  %  P heterogeeneity
                         studies  with     without   or pooled MD   or pooled MD
                                COVID-19  COVID-19  Random effects   Fixed effects
            Demographics
             Age a         20     3962     26897   −2.31 (−3.88, −0.75)  −0.91    0.004**  64       < 0.0001***
                                                                  (−1.43, −0.38)
             Gender (male)  23  2350/4154  36522/70867  1.29 (1.09, 1.54)  1.20 (1.13, 1.28)  0.004**  60  0.0001***
            Stroke subtype (TOAST)
             Small vessel   13   62/564   579/3402  0.64 (0.38, 1.08)  0.65 (0.49, 0.87)  0.10  59   0.004**
             Large artery   12   96/542   645/3354  0.91 (0.67, 1.24)  0.90 (0.70, 1.16)  0.56  24    0.21
             atherosclerosis
             Cardioembolic   12  151/542  939/3354  1.01 (0.82, 1.26)  1.00 (0.81, 1.24)  0.91  0     0.58
             Other known   11    23/470   100/2198  1.11 (0.58, 2.13)  0.99 (0.62, 1.58)  0.75  32    0.14
             cause
             Cryptogenic   11    199/470  654/2198  1.83 (1.24, 2.70)  1.69 (1.36, 2.10)  0.002**  62  0.003**
            Stroke territories
             Anterior      7     146/168   675/913  2.29 (1.03, 5.10)  2.97 (1.77, 4.98)  0.04*  37   0.15
             circulation
             MCA           9     118/281   421/946  0.79 (0.42, 1.50)  0.87 (0.65, 1.18)  0.48  72  0.0004***
             ICA           7     47/229    88/736   1.85 (1.19, 2.88)  1.88 (1.22, 2.90)  0.007*  0   0.73
             Posterior     7     12/168    155/913  0.42 (0.19, 0.95)  0.32 (0.17, 0.59)  0.04*  28   0.21
             circulation
             Multiple      4     37/167    86/930   2.64 (1.62, 4.29)  2.68 (1.66, 4.32)  < 0.0001***  0  0.39
             territories
            Laboratory findings
             CRP, mg/L a   6      310       2120   55.90 (33.32, 78.49)  47.29 (36.16,   < 0.00001***  67  0.009*
                                                                     58.42)
                    3
             WBC, ×10  /µL a  8   316       1772    0.21 (−0.46, 0.88)  0.19 (−0.20, 0.59)  0.54  42  0.10
             APTT b        7      316       1937    0.33 (0.02, 0.64)  0.40 (0.28, 0.52)  0.04*  82  < 0.00001***
             PT b          6      214       1236    0.41 (0.04, 0.79)  0.44 (0.29, 0.59)  0.03*  79  0.0003***
             PLT, ×10 /µL a  9    397       2945   14.78 (−5.31, 34.87) 7.46 (−3.19, 18.12)  0.15  62  0.008*
                   3
             D-dimer b     5      195       1082    0.81 (0.52, 1.10)  0.84 (0.68, 1.00)  < 0.00001***  59  0.04*
            Other stroke characteristics
             NIHSS at      17     1697     45017    3.21 (2.13, 4.29)  3.79 (3.33, 4.25)  < 0.00001***  64  0.0002***
             admission a
             Large vessel   8    437/1428  9358/42561  1.68 (1.10, 2.57)  1.41 (1.25, 1.59)  0.02*  75  0.0002***
             occlusion
             Volume of     2       31       115    33.30 (−12.44, 79.04) 20.27 (4.45, 36.10)  0.15  75  0.04*
             infarction, cm3 a
             ASPECT score a  5     88       829    −0.22 (−1.31, 0.87)  0.29 (−0.19, 0.78)  0.69  74  0.004**
            Overall outcomes of AIS
             HT            6     130/2392  1074/23226  1.34 (0.91, 1.98)  1.11 (0.92, 1.35)  0.14  39  0.15
             sICH          6     15/190    79/1245  1.46 (0.81, 2.62)  1.40 (0.78, 2.49)  0.21  0     0.55
             In-hospital   19    659/2871  2290/29187  3.70 (2.73, 5.02)  3.46 (3.13, 3.82)  < 0.00001***  64  < 0.0001***
             mortality
             Favorable     10    136/415  2811/5250  0.49 (0.39, 0.61)  0.49 (0.39, 0.61)  < 0.00001***  0  0.93
             discharge
                                                                                                       (Contd...)


            Volume 1 Issue 1 (2022)                         7                        https://doi.org/10.36922/an.v1i1.28
   10   11   12   13   14   15   16   17   18   19   20